HIV / AIDS
Jan 15, 2023
A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of combinations of monoclonal antibodies administered via intravenous infusion in healthy, HIV-uninfected adults Web Links:...
Jan 13, 2023
ICAP conducted this study to develop and follow a cohort of HIV-infected adults starting ART at health facilities across Kenya to understand the levels of inflammatory and coagulation biomarkers in clients and the effect of ART on those...
Jan 12, 2023
In close partnership with the Myanmar National AIDS Program (NAP) and the Centers for Disease Control and Prevention (CDC), ICAP evaluated the introduction of a key populations (KP) sensitization training for health care workers and the implementation of structural...
Jan 11, 2023
ICAP partnered with the MOH and National AIDS Centers in Kazakhstan, Kyrgyzstan, and Tajikistan to build national capacity to provide high-quality HIV prevention, care, and treatment services, providing enhanced technical assistance and mentoring to HIV care and...
Jan 10, 2023
ICAP is partnering with MOHs and National AIDS Centers in Kazakhstan, Kyrgyzstan, and Tajikistan to build national capacity to provide high-quality HIV prevention, care, and treatment services, providing enhanced technical assistance and mentoring to HIV care and...